D
David A. Cooper
Researcher at Pfizer
Publications - 965
Citations - 81765
David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
The management of acute laryngo-tracheo-bronchitis (croup): a consensus view.
Kyle S. Dawson,David A. Cooper,Philip J. Cooper,Paul Francis,Richard L. Henry,Alan Isles,A. S. Kemp,L. I. Landau,James Martin,B. Masters,Craig M. Mellis,Ed A. Mitchell,John R. Morton,Anthony Olinsky,Colin F. Robertson,P. Van Asperen,Peter D. Sly,Gary C. Geelhoed,J. D. Gillies +18 more
TL;DR: The management of croup relies upon the traditional clinical skills of observation and examination and Parental involvement is essential and the appropriate reassurance of the patient is important.
Book ChapterDOI
Current Clinical Experience with Nevirapine for HIV Infection
Andrew Carr,David A. Cooper +1 more
TL;DR: Nevirapine is a potent antiretroviral agent whose use, especially as monotherapy, may be limited by rapid onset of resistance as well as by hypersensitivity reactions, however, virologic features of nevirapine suggest that it may be useful in combination therapy with zidovudine or other antireTrovirals, including for patients infected with zirconia-resistant strains HIV.
Journal ArticleDOI
Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia
Supachai Rerks-Ngarm,Punnee Pitisuttithum,Nirmal Kumar Ganguly,Linqi Zhang,Hiko Tamashiro,David A. Cooper,Mean Chhi Vun,Budiman Bela,Rossana Ditangco,Nguyen Van Kinh,Alan Bernstein,Saladin Osmanov,Bonnie J. Mathieson,Stephen J. Kent,Yiming Shao +14 more
TL;DR: An important meeting titled “Defining the Objectives of the AIDS Vaccine Asian Network (AVAN)” was held 22–24 February 2009, in Beijing, and the outcomes of this meeting are described.
Journal ArticleDOI
Prevalence of Anemia and Underlying Iron Status in Naive Antiretroviral Therapy HIV-Infected Children with Moderate Immune Suppression
Pope Kosalaraksa,Torsak Bunupuradah,Saphonn Vonthanak,Surapon Wiangnon,Rawiwan Hansudewechakul,Ung Vibol,Suparat Kanjanavanit,Chaiwat Ngampiyaskul,Jurai Wongsawat,Wicharn Luesomboon,Pagakrong Lumbiganon,Bunruan Sopa,Tanakorn Apornpong,Theshinee Chuenyam,David A. Cooper,Kiat Ruxrungtham,Jintanat Ananworanich,Thanyawee Puthanakit +17 more
TL;DR: A routine prescription of iron supplement in anemic HIV-infected children without laboratory confirmation of IDA should be discouraged, especially in regions with a high prevalence of thalassemia and low prevalence ofIDA.
Journal ArticleDOI
Successful management of lymphangiomatosis and chylothorax in a 7-month-old infant
TL;DR: Resection of the patient’s spleen and partial pleurectomy were associated with a dramatic improvement in his condition and at 27 months the patient was well with no evidence of further lymphangiomas or a recurrence of his chylothoraces.